China Pharma Holdings, Inc.
CPHI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,736 | -$3,079 | -$3,973 | -$3,399 |
| Dep. & Amort. | $2,618 | $2,754 | $2,701 | $3,088 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $78 | $15 |
| Change in WC | $1,195 | -$396 | $878 | $52 |
| Other Non-Cash | $456 | $22 | -$94 | -$5 |
| Operating Cash Flow | -$466 | -$700 | -$410 | -$250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38 | -$12 | -$402 | -$438 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$253 | $0 | $0 | $0 |
| Investing Cash Flow | -$292 | -$12 | -$402 | -$438 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $27 | $73 | -$1,547 | $4,598 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$223 | $0 |
| Financing Cash Flow | $27 | $73 | -$1,770 | $4,598 |
| Forex Effect | -$66 | $32 | -$248 | -$8 |
| Net Chg. in Cash | -$797 | -$606 | -$2,829 | $3,901 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,424 | $2,030 | $4,859 | $958 |
| End Cash | $627 | $1,424 | $2,030 | $4,859 |
| Free Cash Flow | -$758 | -$711 | -$812 | -$688 |